Genomictree Inc. Net Asset Momentum
Genomictree Inc. net asset momentum. Genomictree Inc. (228760) recorded a net asset momentum of -7.2% as of December 2025, with net assets of ₩115.31 Billion KRW. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore Genomictree Inc. (228760) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Genomictree Inc. (2020–2025)
Net asset momentum of Genomictree Inc. from 2020 to 2025. This chart tracks Genomictree Inc.'s year-over-year net asset growth across 6 annual reporting periods from 2020 to 2025. The most recent momentum reading is -7.2%, with net assets of ₩115.31 Billion KRW as of December 2025. See Genomictree Inc. (228760) net assets for net asset value and shareholders' equity analysis.
Genomictree Inc. Net Asset Momentum by Year (2020–2025)
Genomictree Inc. net asset momentum by year from 2020 to 2025. The table below shows the complete annual net asset history for Genomictree Inc. from 2020 to 2025, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see 228760 company net worth.
| Year | Net Assets (KRW) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | ₩115.31 Billion | ₩120.76 Billion | ₩5.45 Billion | ▼ -7.2% |
| 2024 | ₩124.32 Billion | ₩130.68 Billion | ₩6.36 Billion | ▼ -0.6% |
| 2023 | ₩125.03 Billion | ₩132.84 Billion | ₩7.81 Billion | ▲ +16.8% |
| 2022 | ₩107.05 Billion | ₩162.91 Billion | ₩55.86 Billion | ▼ -7.0% |
| 2021 | ₩115.10 Billion | ₩177.15 Billion | ₩62.05 Billion | ▲ +20.8% |
| 2020 | ₩95.26 Billion | ₩117.90 Billion | ₩22.64 Billion | — |